• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PERFUSION SYSTEMS FUSION HOLLOW FIBER OXYGENATOR; OXYGENATOR, CARDIOPULMONARY BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PERFUSION SYSTEMS FUSION HOLLOW FIBER OXYGENATOR; OXYGENATOR, CARDIOPULMONARY BYPASS Back to Search Results
Model Number BB811
Device Problem Fluid/Blood Leak (1250)
Patient Problems Hemorrhage/Bleeding (1888); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 09/25/2023
Event Type  malfunction  
Event Description
Medtronic received information that during use of a fusion oxygenator, the customer reported that the cardiopulmonary bypass circuit had been primed ready for the case.The customer observed a few drops of clear fluid on the floor beneath the oxygenator.The customer thought it was condensation or drips from the heater cooler line.Once the pump suckers were switched on and blood was introduced into the circuit the drips were indicative of a blood leak.The customer stated that they could not pinpoint the exact area of the leak but believed it was from the central dome at the top of the oxygenator.The device was replaced to complete the procedure.There was no adverse patient effect associated with this event.Medtronic received additional information that the customer stated that the leak was from the device itself, not tubing.The customer reported that they were unsure of exact location as the drips were seen on the floor.The customer described it as the dome at the top of the oxygenator.There was no damage to the device, the packaging or other contents within the package (ex.Devices in a tray or custom pack).The patient lost a few drips, less than 10mls, as a result of the leak.There was no transfusion required as a result of the leak.The customer stated that the bypass circuit was not connected to the patient, therefore, the patient had not been cannulated so no patient effect.Only the pump suckers were in the operation.
 
Manufacturer Narrative
Device evaluation summary: visual inspection shows no outward signs of physical damage or abnormalities.Pressure integrity testing was performed at 3 l/pm with 23 psi, (1189 mmhg) of back pressure for 10 minutes.During the pressure integrity testing there was a leak observed from the top of the device.Reason for return was confirmed.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
Correction h3.0 (device evaluated?) and h3.2 (dev ret to mfr?): these fields have been updated as the device was returned and analyzed.The device evaluation summary was included in the initial report 2184009-2023-01036.Correction h6.0 patient codes (ime/annex e): this code has been updated.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FUSION HOLLOW FIBER OXYGENATOR
Type of Device
OXYGENATOR, CARDIOPULMONARY BYPASS
Manufacturer (Section D)
PERFUSION SYSTEMS
7611 northland dr
brooklyn park MN 55428
Manufacturer (Section G)
PERFUSION SYSTEMS
7611 northland dr
brooklyn park MN 55428
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key18109545
MDR Text Key327896917
Report Number2184009-2023-01036
Device Sequence Number1
Product Code DTZ
UDI-Device Identifier00643169178168
UDI-Public00643169178168
Combination Product (y/n)N
Reporter Country CodeUK
PMA/PMN Number
K203111
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 12/15/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/10/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Model NumberBB811
Device Catalogue NumberBB811
Device Lot Number226027314
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/19/2023
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/12/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured03/08/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-